HELP YOUR PATIENTS overcome the barriers of

facial and truncal acne.

Not an actual patient.

Facial acne is only half the story.

Person figures represent statistic that 52% of patients with facial acne also have truncal acne

52^%

OF PATIENTS WITH FACIAL ACNE
ALSO HAVE TRUNCAL ACNE¹

Patients with truncal acne often suffer from self-consciousness and social withdrawal.² They also feel embarrassed by the acne on their trunk, but still focus more on their facial acne when speaking with their dermatology providers.^1,2

MOST patients want treatment FOR TRUNCAL ACNE.¹

78^%

OF PATIENTS PRESENT WITH
FACIAL ACNE BUT ALSO
WANT TREATMENT FOR THEIR
TRUNCAL ACNE¹

Person figures represent 78% of patients present with facial acne but also want treatment for their truncal acne

AKLIEF® (trifarotene) Cream, 0.005% product packaging box and bottle next to teen female swinging tennis racket

With AKLIEF^® (trifarotene) Cream, 0.005% YOU CAN HELP GIVE YOUR PATIENTS ACNE RELIEF.

References: 1. Tan J, Thiboutot D, Popp G, et al. Randomized phase 3 evaluation of trifarotene 50 µg/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80(6):1691-1699. 2. Blume-Peytavi U, Fowler J, Kemény L, et al. Long-term safety and efficacy of trifarotene 50 µg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne. J Eur Acad Dermatol Venereol. 2020;34(1):166-173.

IMPORTANT SAFETY INFORMATION

Indication: AKLIEF^® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Warnings/Precautions: Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of treatment, and, if appropriate, depending upon the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin. Use of “waxing” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

See Important Safety Information.

Your use of this website is subject to our Updated Privacy Policy. Click here to read more.